| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel germline hyperactivating JAK2 mutation L604F
|
Dvořáček, Lukáš
|
|
|
102 |
10 |
p. 2725-2734
|
artikel
|
| 2 |
A prediction model for severe hematological toxicity of BTK inhibitors
|
Jiang, Dan
|
|
|
102 |
10 |
p. 2765-2777
|
artikel
|
| 3 |
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region
|
Sticchi Damiani, Alessia
|
|
|
102 |
10 |
p. 2923-2931
|
artikel
|
| 4 |
Association between anemia and depression: results from NHANES 2005–2018 and mendelian randomization analyses
|
Wang, Yashan
|
|
|
102 |
10 |
p. 2651-2658
|
artikel
|
| 5 |
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma
|
Rago, A.
|
|
|
102 |
10 |
p. 2977-2978
|
artikel
|
| 6 |
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease
|
He, Qing
|
|
|
102 |
10 |
p. 2857-2864
|
artikel
|
| 7 |
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study
|
Qiu, Qunxiang
|
|
|
102 |
10 |
p. 2671-2682
|
artikel
|
| 8 |
Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data
|
Can, Ferda
|
|
|
102 |
10 |
p. 2645-2650
|
artikel
|
| 9 |
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
|
Duan, Wenbing
|
|
|
102 |
10 |
p. 2695-2705
|
artikel
|
| 10 |
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
|
Iemura, Tomoki
|
|
|
102 |
10 |
p. 2909-2922
|
artikel
|
| 11 |
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma
|
Gong, Chen
|
|
|
102 |
10 |
p. 2845-2855
|
artikel
|
| 12 |
Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series
|
Zhang, Yue-Hua
|
|
|
102 |
10 |
p. 2803-2813
|
artikel
|
| 13 |
Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
|
Corbingi, Andrea
|
|
|
102 |
10 |
p. 2735-2740
|
artikel
|
| 14 |
Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia
|
Shah, Anjali
|
|
|
102 |
10 |
p. 2683-2693
|
artikel
|
| 15 |
Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma
|
García-Baztán, Agurne
|
|
|
102 |
10 |
p. 2823-2834
|
artikel
|
| 16 |
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3
|
Komeno, Yukiko
|
|
|
102 |
10 |
p. 2947-2949
|
artikel
|
| 17 |
Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis
|
Chen, Xinyue
|
|
|
102 |
10 |
p. 2933-2942
|
artikel
|
| 18 |
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
|
Burns, Ethan A.
|
|
|
102 |
10 |
p. 2753-2763
|
artikel
|
| 19 |
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
|
Yanagihara, Toyoshi
|
|
|
102 |
10 |
p. 2959-2961
|
artikel
|
| 20 |
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
|
Tian, Mengru
|
|
|
102 |
10 |
p. 2943-2945
|
artikel
|
| 21 |
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
|
Di Rocco, Alice
|
|
|
102 |
10 |
p. 2963-2964
|
artikel
|
| 22 |
One disease, two faces: clonally-related AML and MPDCP with skin involvement
|
Martino, Giovanni
|
|
|
102 |
10 |
p. 2969-2971
|
artikel
|
| 23 |
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era
|
Qi, Feiyang
|
|
|
102 |
10 |
p. 2707-2716
|
artikel
|
| 24 |
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
|
Araie, Hiroaki
|
|
|
102 |
10 |
p. 2879-2893
|
artikel
|
| 25 |
Real-life experience with luspatercept in transfusion-dependent β-thalassemia
|
Roccotelli, Daniela
|
|
|
102 |
10 |
p. 2965-2967
|
artikel
|
| 26 |
Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions
|
Deenadayalan, Vaishali
|
|
|
102 |
10 |
p. 2659-2669
|
artikel
|
| 27 |
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension
|
Mulas, Olga
|
|
|
102 |
10 |
p. 2717-2723
|
artikel
|
| 28 |
Role of body composition and metabolic parameters extracted from baseline 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma
|
Chen, Yang
|
|
|
102 |
10 |
p. 2779-2789
|
artikel
|
| 29 |
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
|
Liu, Jiapei
|
|
|
102 |
10 |
p. 2865-2877
|
artikel
|
| 30 |
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial
|
Kurita, Naoki
|
|
|
102 |
10 |
p. 2895-2902
|
artikel
|
| 31 |
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases
|
Wang, Yupeng
|
|
|
102 |
10 |
p. 2973-2975
|
artikel
|
| 32 |
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
|
Isfort, Susanne
|
|
|
102 |
10 |
p. 2741-2752
|
artikel
|
| 33 |
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
|
Li, Jian
|
|
|
102 |
10 |
p. 2955-2957
|
artikel
|
| 34 |
Successful treatment of systemic mastocytosis with acute myeloid leukemia: a case report
|
Zhou, Minran
|
|
|
102 |
10 |
p. 2951-2953
|
artikel
|
| 35 |
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
|
Fischer, Luca
|
|
|
102 |
10 |
p. 2791-2801
|
artikel
|
| 36 |
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India
|
Roy Moulik, Nirmalya
|
|
|
102 |
10 |
p. 2835-2844
|
artikel
|
| 37 |
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
|
Goveia, Lilian
|
|
|
102 |
10 |
p. 2815-2822
|
artikel
|
| 38 |
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
|
Cremer, Anjali
|
|
|
102 |
10 |
p. 2903-2908
|
artikel
|
Tijdschrift beschrijving